Google finance, business chiefs get millions in bonuses
SAN FRANCISCO (Reuters) - Google Inc (GOOG.O) will pay Finance Chief Patrick Pichette a $3 million annual bonus, and Chief Business Officer Nikesh Arora a $3.5 million bonus, a slight increase from the previous year, following a year in which the Internet company's stock surged nearly 60 percent.
Google Chief Executive Larry Page and co-founder Sergey Brin will receive no bonus, the company said Monday in a filing with the U.S. Securities and Exchange Commission, continuing the founders' practice of not taking a bonus. Page and Brin, who are each paid a $1 a year in salary, have a large portion of their personal wealth tied directly to Google's stock.
Google's shares shot up 58 percent in 2013, breaking the $1,000 mark for the first time and outpacing the Nasdaq's 38 percent gain for the year.
Google Chief Legal Officer and head of Corporate Development David Drummond will receive a $3 million bonus, Google said. Drummond's bonus last year was $3.3 million.
Pichette and Arora each collected bonuses of $2.8 million last year.
In February, Google said it would pay Executive Chairman Eric Schmidt a $6 million discretionary cash bonus and awarded him $100 million in restricted stock units.
Shares of Google finished Monday's regular session down 0.3 percent, or $3.22, at $1,211.57.
(Reporting by Alexei Oreskovic; Editing by Jonathan Oatis)
- Tweet this
- Share this
- Digg this
- U.S. strikes have slowed Iraq militants but not weakened them - Pentagon
- Indian economy warms in after-glow of Modi's triumph
- Catalina Island in California suffers damage from Hurricane Marie
- Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk
- Tennis - Dream run over for Bellis as big guns advance
Half of India's thermal power stations have less than a week's supply of coal on hand, according to weekly data, the lowest level since mid-2012 when millions of people were left without power in one of the world's worst blackouts. Full Article
In race for bigger margins, drug makers willing to lose the India "advantage". Full Article